title: Effects of varenicline on cognitive function in non-smokers with schizophrenia.
authors.affiliation: Institute of Medical Sciences (IMS), University of Toronto, Toronto, Ontario, Canada; Addictions Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada. Electronic address: karolina.kozak@camh.ca.
authors.forename: Karolina
authors.initials: K
authors.lastname: Kozak
authors.affiliation: Addictions Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
authors.forename: Sarah S
authors.initials: SS
authors.lastname: Dermody
authors.affiliation: Institute of Medical Sciences (IMS), University of Toronto, Toronto, Ontario, Canada; Addictions Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
authors.forename: Rachel A
authors.initials: RA
authors.lastname: Rabin
authors.affiliation: Institute of Medical Sciences (IMS), University of Toronto, Toronto, Ontario, Canada; Molecular Brain Science Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
authors.forename: Martin
authors.initials: M
authors.lastname: Zack
authors.affiliation: Institute of Medical Sciences (IMS), University of Toronto, Toronto, Ontario, Canada; Addictions Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada; Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Mera S
authors.initials: MS
authors.lastname: Barr
authors.affiliation: Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Molecular Brain Science Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
authors.forename: Rachel F
authors.initials: RF
authors.lastname: Tyndale
authors.affiliation: Institute of Medical Sciences (IMS), University of Toronto, Toronto, Ontario, Canada; Addictions Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada; Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
authors.forename: Tony P
authors.initials: TP
authors.lastname: George
mesh_terms: D000328:Adult; D060825:Cognitive Dysfunction / Q000188:drug therapy* / Q000209:etiology; D004311:Double-Blind Method; D006801:Humans; D008570:Memory, Short-Term / Q000187:drug effects*; D018722:Nicotinic Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D000078405:Non-Smokers; D012559:Schizophrenia / Q000150:complications*; D013028:Space Perception / Q000187:drug effects; D016896:Treatment Outcome; D000068580:Varenicline / Q000008:administration & dosage / Q000494:pharmacology*; D014796:Visual Perception / Q000187:drug effects
chemical_list: D018722:Nicotinic Agonists; D000068580:Varenicline
keywords: Cognition; Non-smokers; Schizophrenia; Varenicline; Visuospatial working memory